B. Strober, K. A. Papp, M. Flack, Y. Gu, E. H. Thompson, and W. C. Valdecantos, “Distribution of Improvements in Psoriasis Area and Severity Index from the Phase 2 Trial of Risankizumab in Moderate-to-Severe Plaque Psoriasis”, J of Skin, vol. 1, no. 3.1, p. s10, Oct. 2017.